Health Care Providers & Services · NYSE

DVADavita Inc.

Last close
$174.56 +0.3%
52-week range
$101.00 to $247.49
Market cap
$11.0B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$13.6B
+6% vs FY24
Net income
$747M
-20% vs FY24
Free cash flow
$1.31B
-11% vs FY24
Net cash
-$9.57B
Cash $701M, debt $10.3B

Stock price

+163% since Dec 2016

Valuation vs its own 10 years

Below its 10-year median on all 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
12.9x
9.9x76.5x
22nd percentile, below its median of 14.6x
Price / sales
0.8x
0.6x1.2x
28th percentile, below its median of 0.9x
EV / EBITDA
7.5x
6.4x11.4x
39th percentile, below its median of 7.8x
Price / free cash flow
8.5x
6.0x24.6x
40th percentile, below its median of 9.0x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
12.9x
Earnings yield
7.8%
Price / sales
0.8x
Price / book
n/aNot reported
Price / operating cash flow
5.9x
EV / EBITDA
7.5x
EV / sales
1.5x
Free cash flow yield
11.8%

Profitability

Gross margin
n/aNot reported
Operating margin
15.0%
Net margin
6.5%
Return on equity
n/aNegative equity
Return on capital
16.4%

Growth per year

Revenue, 3 years
+5.5%
Revenue, 5 years
+3.4%
Revenue, 9 years
+2.7%
EPS, 3 years
+18.9%

Balance sheet

Cash and investments
$566M
Total debt
$10.8B
Net cash
-$10.2B
Debt / equity
n/aNegative equity
Current ratio
1.41x

Shares and dividend

Shares outstanding
62.9M
Share count, 5 years
-38.1%
Beta, 1 year
-0.03
Dividend yield
n/a
Dividend per share, TTM
n/a
Payout ratio
n/a

n/a: No dividend

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $3.58B
RevenueNet income
EBITDALatest quarter $664M
Margins14 / 6%
GrossOperatingNet
Earnings per shareLatest quarter $3.40
Cash flowLatest quarter $519M
OperatingCapexFree
Cash vs debtLatest quarter $566M
Cash and investmentsTotal debt
P/E historyNow 12.9x
P/E, median 14.6x dashed
P/S historyNow 0.8x
P/S, median 0.9x dashed

Where the revenue comes from

US Dialysis and Related Lab Services went from 89% to 86% of revenue in 2 years

Share of revenue by business segment, fiscal 2023 to 2025, as reported in the 10-K.

US Dialysis and Related Lab ServicesAll Other Segments
FY23
89%11%
$12.1B
FY24
88%12%
$12.8B
FY25
86%14%
$13.6B
Fiscal 2025 by business segment
Business segmentRevenueSharevs FY24
US Dialysis and Related Lab Services$11.7B86.0%+4%
All Other Segments$1.91B14.0%+28%

Health Care Providers & Services peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
UNH Unitedhealth Group Inc $365B +3% 5.3%23.3x0.8x 68th percentile
MCK Mckesson Corp $127B +8% 1.6%28.4x0.3x 78th percentile
CVS CVS HEALTH Corp $114B +7% 3.6%10.4x0.3x 10th percentile
HCA HCA Healthcare, Inc. $104B +6% n/a16.5x1.3x 95th percentile
ELV Elevance Health, Inc. $92.8B +4% 2.7%18.3x0.5x 70th percentile
DVA Davita Inc. $11.0B +6% 15.0%12.9x0.8x 22nd percentile

The company

Sector
Health Care
Industry
Health Care Providers & Services
Founded
1994
Headquarters
Denver, CO
Fiscal year ends
December
Website
davita.com

What it does

DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about DVA.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 361 active funds. Crowd level: quiet, 2 rising quarters.

Open the Smart money tab